Skip to main content

Closed

RARE: Ultragenyx Pharmaceutical Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

31thpctl

Volume

0.70×avg

Market Cap

2.45BUSD

P/E Ratio

-4.1TTM

Div Yield

-ann

Ultragenyx Pharmaceutical Inc.

RARENASDAQ Global Select·USD·Closed

Ultragenyx Pharmaceutical Inc.

RARENASDAQ·USD·Closed

$24.91

−4.34%

$24.91

−$1.13 (4.34%)

52W Range

31thpctl

Volume

0.70×avg

Mkt Cap

2.45BUSD

P/E

-4.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings